Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)

SHA:688217 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	111.92	139.19	161.95	204.22	123.76	142.57
Trading Asset Securities	112.01	93.53	72.36	90.61	201.11	-
Cash & Short-Term Investments	223.93	232.72	234.31	294.83	324.88	142.57
Cash Growth	-1.57%	-0.68%	-20.53%	-9.25%	127.88%	-2.92%
Accounts Receivable	174.78	171.26	187.96	256.42	164.54	167.88
Other Receivables	1.97	11.39	11.07	4.42	7.03	0.03
Receivables	176.75	182.66	199.03	260.84	171.57	167.91
Inventory	45.16	43.4	60.65	53.96	37.27	27.05
Other Current Assets	25.53	11.36	15.9	14.86	22.58	51.58
Total Current Assets	471.36	470.14	509.9	624.48	556.3	389.11
Property, Plant & Equipment	358.64	366.12	365.34	276.01	212.77	165.73
Long-Term Investments	47.92	47.92	47.76	56.76	56.76	47.76
Goodwill	11.12	11.12	25.43	32.92	46.31	46.31
Other Intangible Assets	38.63	41.06	49.61	40.04	46.35	44.86
Long-Term Deferred Tax Assets	22.34	20.86	16.7	10.26	3.94	4.96
Long-Term Deferred Charges	1.82	2.03	1.96	0.93	3.01	7.17
Other Long-Term Assets	25.26	26.45	27.46	42.46	22.09	5.82
Total Assets	977.11	985.7	1,044	1,084	947.53	711.71
Accounts Payable	18.21	11.27	14.37	51.18	11.18	12.34
Accrued Expenses	11.43	14.2	17.62	21.42	13.4	14.59
Short-Term Debt	-	1.51	1.51	2.86	0.88	0.39
Current Portion of Leases	3.29	5.41	5.82	2.97	4.7	-
Current Income Taxes Payable	4.59	2.18	0.11	7.41	0.26	1.27
Current Unearned Revenue	1.69	2.12	2	2.84	1.7	8.28
Other Current Liabilities	4.93	2.03	1.18	1.42	1.32	0.65
Total Current Liabilities	44.15	38.72	42.61	90.09	33.44	37.52
Long-Term Debt	-	13.75	16.25	-	-	-
Long-Term Leases	1.39	1.75	5.75	8.1	3.96	-
Long-Term Unearned Revenue	1.26	1.34	1.68	2.02	4.35	2.81
Long-Term Deferred Tax Liabilities	4.43	4.91	6.81	8.16	5.52	6.09
Other Long-Term Liabilities	3.39	4.59	3.39	4.08	3.6	3.5
Total Liabilities	54.62	65.06	76.48	112.45	50.87	49.92
Common Stock	55.86	55.86	55.86	55.58	55.58	41.68
Additional Paid-In Capital	732.16	732.16	735.89	725.16	717.56	536.66
Retained Earnings	141.62	138.26	154.03	156.16	115.68	68.35
Treasury Stock	-17.03	-17.03	-	-	-	-
Total Common Equity	912.61	909.26	945.78	936.9	888.81	646.69
Minority Interest	9.87	11.39	21.9	34.53	7.85	15.1
Shareholders' Equity	922.49	920.64	967.68	971.42	896.67	661.79
Total Liabilities & Equity	977.11	985.7	1,044	1,084	947.53	711.71
Total Debt	4.69	22.42	29.33	13.92	9.53	0.39
Net Cash (Debt)	219.24	210.3	204.98	280.91	315.35	142.17
Net Cash Growth	9.78%	2.60%	-27.03%	-10.92%	121.80%	-2.81%
Net Cash Per Share	3.85	3.74	3.62	5.07	6.33	3.42
Filing Date Shares Outstanding	55.19	55.19	55.86	55.58	55.58	41.68
Total Common Shares Outstanding	55.19	55.19	55.86	55.58	55.58	41.68
Working Capital	427.22	431.42	467.29	534.39	522.86	351.58
Book Value Per Share	16.54	16.48	16.93	16.86	15.99	15.52
Tangible Book Value	862.86	857.08	870.74	863.93	796.15	555.51
Tangible Book Value Per Share	15.64	15.53	15.59	15.54	14.33	13.33
Buildings	-	270.1	267.52	88.44	88.44	88.12
Machinery	-	187.48	180.06	168.75	145.41	124.91
Construction In Progress	-	69.94	43.24	115.68	58.61	17.27

Source: S&P Global Market Intelligence. Standard template. Financial Sources.